Forgot your password?
I thought you might be interested in looking at Two years follow–up of an open–label pilot study of treatment with rituximab in patients with early diffuse cutaneous systemic sclerosis (dcSSc)..
Pasted as rich text. Paste as plain text instead
Only 75 emoji are allowed.
Your link has been automatically embedded. Display as a link instead
Your previous content has been restored. Clear editor
You cannot paste images directly. Upload or insert images from URL.